Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by MSD naming David Cullinane .
Filed returns
13
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2024 | MSD | Health | Health Policy Development for New Programme for Government (Public policy or programme) | 46 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | Meeting to discuss health policy matters with the opposition health spokesperson. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Access to innovative cancer medicines (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Policy Priorities in a post-pandemic COVID-19 era (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Immunisation Policies (Public policy or programme) | 26 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Oncology Policy (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Cancer Care in a post-pandemic COVID-19 era (Public policy or programme) | 15 | On lobbying.ie |
| May–Aug 2021 | MSD | Health | Cancer Care in a post-pandemic COVID-19 era (Public policy or programme) | 18 | On lobbying.ie |
| Jan–Apr 2021 | MSD | Health | Oncology Policy (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Policy Priorities in a post-pandemic COVID-19 era (Public policy or programme) | 26 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 34 | On lobbying.ie |
| May–Aug 2020 | MSD | Health | Immunisation Policies (Public policy or programme) | 50 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Economic Development and Industry | Development of the Pharmaceutical industry in Ireland (Public policy or programme) | 91 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 12 | 92.3% | |
| Economic Development and Industry | 1 | 7.7% |